Literature DB >> 27003218

Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.

Kwangsik Nho1,2,3, Andrew J Saykin1,4,2,3, Peter T Nelson5.   

Abstract

Hippocampal sclerosis of aging (HS-Aging) is a common brain disease in older adults with a clinical course that is similar to Alzheimer's disease. Four single-nucleotide polymorphisms (SNPs) have previously shown association with HS-Aging. The present study investigated structural brain changes associated with these SNPs using surface-based analysis. Participants from the Alzheimer's Disease Neuroimaging Initiative cohort (ADNI; n = 1,239), with both MRI scans and genotype data, were used to assess the association between brain atrophy and previously identified HS-Aging risk SNPs in the following genes: GRN, TMEM106B, ABCC9, and KCNMB2 (minor allele frequency for each is >30%). A fifth SNP (near the ABCC9 gene) was evaluated in post-hoc analysis. The GRN risk SNP (rs5848_T) was associated with a pattern of atrophy in the dorsomedial frontal lobes bilaterally, remarkable since GRN is a risk factor for frontotemporal dementia. The ABCC9 risk SNP (rs704180_A) was associated with multifocal atrophy whereas a SNP (rs7488080_A) nearby (∼50 kb upstream) ABCC9 was associated with atrophy in the right entorhinal cortex. Neither TMEM106B (rs1990622_T), KCNMB2 (rs9637454_A), nor any of the non-risk alleles were associated with brain atrophy. When all four previously identified HS-Aging risk SNPs were summed into a polygenic risk score, there was a pattern of associated multifocal brain atrophy in a predominately frontal pattern. We conclude that common SNPs previously linked to HS-Aging pathology were associated with a distinct pattern of anterior cortical atrophy. Genetic variation associated with HS-Aging pathology may represent a non-Alzheimer's disease contribution to atrophy outside of the hippocampus in older adults.

Entities:  

Keywords:  Arteriolosclerosis; KATP; SUR2; TDP-43; dementia; progranulin; rs1990622; rs5848; rs704180; rs9637454

Mesh:

Substances:

Year:  2016        PMID: 27003218      PMCID: PMC4978172          DOI: 10.3233/JAD-160077

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  51 in total

Review 1.  Update on Hippocampal Sclerosis.

Authors:  Juliana R Dutra; Etty P Cortés; Jean Paul G Vonsattel
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Hippocampal sclerosis in Alzheimer disease and other dementias.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

Review 3.  Neuropathology of hippocampal sclerosis.

Authors:  Catalina Amador-Ortiz; Dennis W Dickson
Journal:  Handb Clin Neurol       Date:  2008

4.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

5.  Neuropathologic correlates of regional brain volumes in a community cohort of older adults.

Authors:  Aikaterini Kotrotsou; Julie A Schneider; David A Bennett; Sue E Leurgans; Robert J Dawe; Patricia A Boyle; Tom Golak; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2015-06-30       Impact factor: 4.673

6.  Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals.

Authors:  Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-06       Impact factor: 6.200

7.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

8.  Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.

Authors:  James B Leverenz; Christina M Agustin; Debby Tsuang; Elaine R Peskind; Steven D Edland; David Nochlin; Lillian DiGiacomo; James D Bowen; Wayne C McCormick; Linda Teri; Murray A Raskind; Walter A Kukull; Eric B Larson
Journal:  Arch Neurol       Date:  2002-07

Review 9.  Hippocampal sclerosis dementia: a reappraisal.

Authors:  Alphonse Probst; Kirsten I Taylor; Markus Tolnay
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

10.  TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2007-12-18       Impact factor: 17.088

View more
  12 in total

1.  Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.

Authors:  Peter T Nelson; Yuriko Katsumata; Kwangsik Nho; Sergey C Artiushin; Gregory A Jicha; Wang-Xia Wang; Erin L Abner; Andrew J Saykin; Walter A Kukull; David W Fardo
Journal:  Acta Neuropathol       Date:  2016-11-04       Impact factor: 17.088

Review 2.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

3.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

4.  TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.

Authors:  Peter T Nelson; Zsombor Gal; Wang-Xia Wang; Dana M Niedowicz; Sergey C Artiushin; Samuel Wycoff; Angela Wei; Gregory A Jicha; David W Fardo
Journal:  Neurobiol Dis       Date:  2019-01-23       Impact factor: 5.996

5.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.

Authors:  Elizabeth E Blue; Joshua C Bis; Michael O Dorschner; Debby W Tsuang; Sandra M Barral; Gary Beecham; Jennifer E Below; William S Bush; Mariusz Butkiewicz; Carlos Cruchaga; Anita DeStefano; Lindsay A Farrer; Alison Goate; Jonathan Haines; Jim Jaworski; Gyungah Jun; Brian Kunkle; Amanda Kuzma; Jenny J Lee; Kathryn L Lunetta; Yiyi Ma; Eden Martin; Adam Naj; Alejandro Q Nato; Patrick Navas; Hiep Nguyen; Christiane Reitz; Dolly Reyes; William Salerno; Gerard D Schellenberg; Sudha Seshadri; Harkirat Sohi; Timothy A Thornton; Otto Valadares; Cornelia van Duijn; Badri N Vardarajan; Li-San Wang; Eric Boerwinkle; Josée Dupuis; Margaret A Pericak-Vance; Richard Mayeux; Ellen M Wijsman
Journal:  Dement Geriatr Cogn Disord       Date:  2018-02-27       Impact factor: 2.959

6.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.

Authors:  Kwangsik Nho; Sungeun Kim; Emrin Horgusluoglu; Shannon L Risacher; Li Shen; Dokyoon Kim; Seunggeun Lee; Tatiana Foroud; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Ronald C Petersen; Clifford R Jack; Michael W Weiner; Robert C Green; Arthur W Toga; Andrew J Saykin
Journal:  BMC Med Genomics       Date:  2017-05-24       Impact factor: 3.063

8.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

Review 9.  Polygenic Score Models for Alzheimer's Disease: From Research to Clinical Applications.

Authors:  Xiaopu Zhou; Yolanda Y T Li; Amy K Y Fu; Nancy Y Ip
Journal:  Front Neurosci       Date:  2021-03-29       Impact factor: 4.677

10.  Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration.

Authors:  Libin Zhou; Kwangsik Nho; Maria G Haddad; Nicole Cherepacha; Agne Tubeleviciute-Aydin; Andy P Tsai; Andrew J Saykin; P Jesper Sjöström; Andrea C LeBlanc
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.